Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Perspectives of Decisional Surrogates and Patients Regarding Critical Illness Genetic Research.

Freeman BD, Bolcic-Jankovic D, Kennedy CR, LeBlanc J, Eastman A, Barillas J, Wittgen CM, Indsey K, Mahmood RS, Clarridge BR.

AJOB Empir Bioeth. 2016 Jan 1;7(1):39-47. Epub 2015 May 1.

2.
3.

Exploring determinants of surrogate decision-maker confidence: an example from the ICU.

Bolcic-Jankovic D, Clarridge BR, LeBlanc JL, Mahmood RS, Roman AM, Freeman BD.

J Empir Res Hum Res Ethics. 2014 Oct;9(4):76-85. doi: 10.1177/1556264614545036. Epub 2014 Aug 7.

PMID:
25747298
4.

Surrogate receptivity to participation in critical illness genetic research: aligning research oversight and stakeholder concerns.

Freeman BD, Butler K, Bolcic-Jankovic D, Clarridge BR, Kennedy CR, LeBlanc J, Chandros Hull S.

Chest. 2015 Apr;147(4):979-988. doi: 10.1378/chest.14-0797.

5.

Patients' views on identifiability of samples and informed consent for genetic research.

Hull SC, Sharp RR, Botkin JR, Brown M, Hughes M, Sugarman J, Schwinn D, Sankar P, Bolcic-Jankovic D, Clarridge BR, Wilfond BS.

Am J Bioeth. 2008 Oct;8(10):62-70. doi: 10.1080/15265160802478404.

6.

Do characteristics of HIPAA consent forms affect the response rate?

Bolcic-Jankovic D, Clarridge BR, Fowler FJ Jr, Weissman JS.

Med Care. 2007 Jan;45(1):100-3.

PMID:
17279027
7.

Financial relationships between institutional review board members and industry.

Campbell EG, Weissman JS, Vogeli C, Clarridge BR, Abraham M, Marder JE, Koski G.

N Engl J Med. 2006 Nov 30;355(22):2321-9.

8.

Barriers to the integration of psychosocial factors in medicine: results of a national survey of physicians.

Astin JA, Soeken K, Sierpina VS, Clarridge BR.

J Am Board Fam Med. 2006 Nov-Dec;19(6):557-65.

9.

Developing and implementing new safe practices: voluntary adoption through statewide collaboratives.

Leape LL, Rogers G, Hanna D, Griswold P, Federico F, Fenn CA, Bates DW, Kirle L, Clarridge BR.

Qual Saf Health Care. 2006 Aug;15(4):289-95.

10.

Researchers' views of the acceptability of restrictive provisions in clinical trial agreements with industry sponsors.

Mello MM, Clarridge BR, Studdert DM.

Account Res. 2005 Jul-Sep;12(3):163-91.

PMID:
16634168
11.

Reconciling medications at admission: safe practice recommendations and implementation strategies.

Rogers G, Alper E, Brunelle D, Federico F, Fenn CA, Leape LL, Kirle L, Ridley N, Clarridge BR, Bolcic-Jankovic D, Griswold P, Hanna D, Annas CL.

Jt Comm J Qual Patient Saf. 2006 Jan;32(1):37-50.

PMID:
16514938
12.

Complementary and alternative medical therapy use among Chinese and Vietnamese Americans: prevalence, associated factors, and effects of patient-clinician communication.

Ahn AC, Ngo-Metzger Q, Legedza AT, Massagli MP, Clarridge BR, Phillips RS.

Am J Public Health. 2006 Apr;96(4):647-53. Epub 2005 Dec 27.

13.

Academic medical centers' standards for clinical-trial agreements with industry.

Mello MM, Clarridge BR, Studdert DM.

N Engl J Med. 2005 May 26;352(21):2202-10.

14.

Surveying minorities with limited-English proficiency: does data collection method affect data quality among Asian Americans?

Ngo-Metzger Q, Kaplan SH, Sorkin DH, Clarridge BR, Phillips RS.

Med Care. 2004 Sep;42(9):893-900.

PMID:
15319615
15.

Family perspectives on end-of-life care at the last place of care.

Teno JM, Clarridge BR, Casey V, Welch LC, Wetle T, Shield R, Mor V.

JAMA. 2004 Jan 7;291(1):88-93.

PMID:
14709580
16.

Linguistic and cultural barriers to care.

Ngo-Metzger Q, Massagli MP, Clarridge BR, Manocchia M, Davis RB, Iezzoni LI, Phillips RS.

J Gen Intern Med. 2003 Jan;18(1):44-52.

17.

Data withholding in academic genetics: evidence from a national survey.

Campbell EG, Clarridge BR, Gokhale M, Birenbaum L, Hilgartner S, Holtzman NA, Blumenthal D.

JAMA. 2002 Jan 23-30;287(4):473-80.

PMID:
11798369
18.

Toward a national consumer survey: evaluation of the CABHS and MHSIP instruments.

Eisen SV, Shaul JA, Leff HS, Stringfellow V, Clarridge BR, Cleary PD.

J Behav Health Serv Res. 2001 Aug;28(3):347-69.

PMID:
11497028
19.

Use of consumer ratings for quality improvement in behavioral health insurance plans.

Shaul JA, Eisen SV, Stringfellow VL, Clarridge BR, Hermann RC, Nelson D, Anderson E, Kubrin AI, Leff HS, Cleary PD.

Jt Comm J Qual Improv. 2001 Apr;27(4):216-29.

PMID:
11293838
20.

Stability of attitudes regarding physician-assisted suicide and euthanasia among oncology patients, physicians, and the general public.

Wolfe J, Fairclough DL, Clarridge BR, Daniels ER, Emanuel EJ.

J Clin Oncol. 1999 Apr;17(4):1274.

PMID:
10561189
21.
22.

Euthanasia and physician-assisted suicide: attitudes and experiences of oncology patients, oncologists, and the public.

Emanuel EJ, Fairclough DL, Daniels ER, Clarridge BR.

Lancet. 1996 Jun 29;347(9018):1805-10.

PMID:
8667927
23.

Reaching children of the uninsured and underinsured in two rural Wisconsin counties: findings from a pilot project.

Clarridge BR, Larson BJ, Newman KM.

J Rural Health. 1993 Winter;9(1):40-9.

PMID:
10124198
24.

Verbal consultation regarding prescription drugs: findings from a statewide study.

Wiederholt JB, Clarridge BR, Svarstad BL.

Med Care. 1992 Feb;30(2):159-73. Review.

PMID:
1736021
25.

Block grant nutrition services in Wisconsin: an empirical view.

Clarridge BR, Petersen LJ, Spaans-Esten L.

J Am Diet Assoc. 1991 Jun;91(6):695-700.

PMID:
2040785
26.

The use of female spouse proxies in common symptom reporting.

Clarridge BR, Massagli MP.

Med Care. 1989 Apr;27(4):352-66.

PMID:
2704258

Supplemental Content

Loading ...
Support Center